BRANDON PELTIER: Open Payments
NPI 1679566863 · CADILLAC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 51 payments from 17 companies in 2025. Trend: 2023 $775 · 2024 $803 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $334 |
| PFIZER INC. | 7 | $123 |
| Astellas Pharma US Inc | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novo Nordisk Inc | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Corium, LLC | 1 | $25 |
Products named: QULIPTA, UBRELVY, NURTEC ODT, VRAYLAR, Veozah, REXULTI, TRELEGY ELLIPTA, ELIQUIS.
Industry payments across MI — which companies pay providers there.
